Every article on this site is written by AI from official sources and checked by a second AI. How it works
Final ruleTook effect Jan. 1, 2026

Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Dec. 31, 2025. Document 2025-24123. Updated Nov. 16, 2026.

What it does

The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.

The Drug Enforcement Administration's summary, as published in the Federal Register.

What changed in the regulation

2 parts of Title 21, 42 of the Code of Federal Regulations:

21 CFR 1307, 42 CFR 12

Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).

Compared with

The Drug Enforcement Administration has published 27 final rules in 2026 so far, compared with 17 in all of 2025.

Counted by the Tribune from Federal Register records since Jan. 1, 2025.

What happens next and when

This rule is effective January 1, 2026 through December 31, 2026.

The agency's dates, word for word.

Reginfo.gov lists a rule with this regulation identifier as under review at the White House Office of Information and Regulatory Affairs since Aug. 25, 2026 (stage: Final Rule). See it

Document number2025-24123
ActionTemporary rule.
AgenciesJustice Department; Drug Enforcement Administration; Health and Human Services Department
PublishedDec. 31, 2025
Effective dateJan. 1, 2026
Regulation identifier (RIN)1117-AB40, 1117-AB78, 1117-ZA07
DocketHHS-OS-2025-0001
Significant (marked in the Federal Register)Yes

Source: the Federal Register (public domain). The document in the Federal Register